Board appointment at EUSA Pharma
This article was originally published in Scrip
Executive Summary
EUSA Pharma (UK/US), a speciality pharmaceutical company focused on the in-licensing, development and marketing of late-stage oncology, pain control and critical care products, has appointed Stephen Stamp as an independent non-executive director. He has previously held board-level roles at Xanodyne Pharmaceuticals and Shire Pharmaceuticals, and was most recently chief financial officer at K-V Pharmaceutical Company.